Cyclorphan
From Wikipedia, the free encyclopedia
Jump to: navigation, search
![]() |
|
Identifiers | |
---|---|
|
|
CAS Number | |
PubChem CID | |
ChemSpider | |
ChEMBL | |
ECHA InfoCard | 100.021.825 |
Chemical and physical data | |
Formula | C20H27NO |
Molar mass | 297.434 g/mol |
3D model (Jmol) | |
Density | 1.19 g/cm3 |
Melting point | 188 °C (370 °F) |
Boiling point | 458.4 °C (857.1 °F) |
|
Cyclorphan is an opioid analgesic of the morphinan family that was never marketed.[1] It acts as a μ-opioid receptor (MOR) weak partial agonist or antagonist, κ-opioid receptor (KOR) full agonist, and, to a much lesser extent, δ-opioid receptor (DOR) agonist (75-fold lower affinity relative to the KOR).[2][3] The drug was first synthesized in 1964 by scientists at Research Corporation.[4][5]:232 In clinical trials, it had relatively long duration, good absorption, and provided strong pain relief but produced psychotomimetic effects via KOR activation, so its development was not continued.[1][5]:232, 237
See also[edit]
References[edit]
- ^ a b Maxwell Gordon (2 December 2012). Psychopharmacological Agents. Elsevier Science. pp. 19–. ISBN 978-0-323-15963-0.
- ^ Linda P. Dwoskin (29 January 2014). Emerging Targets & Therapeutics in the Treatment of Psychostimulant Abuse. Elsevier Science. pp. 403–. ISBN 978-0-12-420177-4.
- ^ Aldrich JV, Vigil-Cruz SC (2003). "Narcotic Analgesics". Burger's Medicinal Chemistry and Drug Discovery (7th ed.). pp. 331–482. doi:10.1002/0471266949.bmc100. ISBN 9780471266945.
- ^ US Patent 3,285,922
- ^ a b Varghese V & Hudlicky T. A Short History of the Discovery and Development of Naltrexone and Other Morphine Derivatives. Chapter 6 in Natural Products in Medicinal Chemistry, Volume 60 of Methods and Principles in Medicinal Chemistry. Ed. Stephen Hanessian. John Wiley & Sons, 2013. ISBN 9783527676552
Opioids | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Paracetamol-type | |||||||||||||||||||||||||||||||
NSAIDs |
|
||||||||||||||||||||||||||||||
Cannabinoids | |||||||||||||||||||||||||||||||
Ion channel modulators |
|
||||||||||||||||||||||||||||||
Myorelaxants | |||||||||||||||||||||||||||||||
Others | |||||||||||||||||||||||||||||||
|
MOR |
|
---|---|
DOR |
|
KOR |
|
NOP |
|
Unsorted | |
Others |
|
See also: Peptide receptor modulators
|
![]() |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
Hidden categories:
- Pages using ISBN magic links
- ECHA InfoCard ID from Wikidata
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- All stub articles